The revision of the EU Blood Directive by the European commission is now confirmed. The Commission’s Work Programme 2021 includes a legislative proposal (expected in Q4 2021). The review will aim to “allow for more flexible alignment to scientific and technological developments”. The inception impact assessment is expected by the end of the year. You can find a link to the work programme annex document here (p16, point 37).